Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Kammertöns, Thomas Dr. (5) Kopp, Joachim Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (5) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (4) Walther, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (9) (-) Blankenstein, Thomas Prof. Dr. (30) Biologie maligner Lymphome (6) Entwicklungsneurobiologie (1) (-) Molekulare Immunologie und Gentherapie (30) (-) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) (-) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) (-) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) (-) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) 2015 (3) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 30 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 1992199820052010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1998 / Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen 20. Mai 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein 01. Juli 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert 05. Juli 2005 / World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel 01. September 2005 / Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein 01. Januar 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein 01. Januar 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein 01. Januar 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel 01. Januar 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel 01. Januar 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Januar 1998 / Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen
20. Mai 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein
01. Juli 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert
05. Juli 2005 / World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel
01. September 2005 / Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein
01. Januar 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein
01. Januar 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein
01. Januar 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel
01. Januar 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel
01. Januar 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein